Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma

British Journal of Cancer

Volumn 110, Issue 10, 2014, Pages 2560-2568

  Han, S ^a   Zhang, C ^b   Li, Q ^a   Dong, J ^a   Liu, Y ^a   Huang, Y ^a   Jiang, T ^b   Wu, A ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REGULATORY T LYMPHOCYTE; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLIOMA; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 84900527836     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.162     Document Type: Article

References (32)

1. Bos R, Marquardt KL, Cheung J, Sherman La (2012) Functional differences between low-and high-affinity CD8(+) T cells in the tumor environment. Oncoimmunology 1: 1239-1247.
2. Bos R, Sherman La (2010) CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res 70: 8368-8377.
3. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26: 2192-2197.
4. Brandsma D, Van Den Bent MJ (2009) Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 22: 633-638.
5. Brooks WH, Markesbery WR, Gupta GD, Roszman TL (1978) Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4: 219-224.
6. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol 3: 991-998.
7. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22: 329-360.
8. El Andaloussi A, Lesniak MS (2006) An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. Neuro Oncol 8: 234-243.
9. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797.
10. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagor ce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
11. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593.
12. Gobert M Treilleux I Bendriss-Vermare N Bachelot T Goddard-Leon S Arfi V Biota C Doff in AC Durand I Olive D Perez S Pasqual N Faure C Ray-Coquard I Puisieux A Caux C Blay JY Menetrier-Caux C 2009 Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lympho id infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome Cancer Res 69 2000-2009.
13. Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, De Wind A, Ravoet M, Le BH, Sibille C, Manfouo-Foutsop G, Veys I, Haibe-Kains B, Singhal SK, Michiels S, Rothe F, Salgado R, Duvillier H, Ignatiadis M, Desmedt C, Bron D, Larsimont D, Piccart M, Sotiriou C, Willard-Gallo K (2013) CD4+ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 123: 2873-2892.
14. Han S, Xia J, Qin X, Han S, Wu A (2013) Phosphorylated SATB1 is associated with the progression and prognosis of glioma. Cell Death Dis 4: E901.
15. Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W, Qiao W, Hiraoka N, Fuller GN (2008) Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res 14: 5166-5172.
16. Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progressi on of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12: 5423-5434.
17. Ho WY, Yee C, Greenberg PD (2002) Adoptive therapy with CD8(+) T cells: It may get by with a little help from its friends. J Clin Invest 110: 1415-1417.
18. Kim YH, Jung TY, Jung S, Jang WY, Moon KS, Kim IY, Lee MC, Lee JJ (2012) Tumour-infiltrating T-cell subpopulations in glioblastomas. Br J Neurosurg 26: 21-27.
19. Lohr J, Ratliff T, Huppertz A, Ge Y, Dictus C, Ahmadi R, Grau S, Hiraoka N, Eckstein V, Ecker RC, Korff T, Von DA, Unterberg A, Beckhove P, Herold-Mende C (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta. Clin Cancer Res 17: 4296-4308.
20. Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR (2011) Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29: 1949-1955.
21. Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH, Galon J (2009) In situ cyto toxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 27: 5944-5951.
22. Palma L, Di LN, Guidetti B (1978) Lymphocytic infiltrates in primary glioblastomas and recidivous g liomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49: 854-861.
23. Perrin G, Schnuriger V, Quiquerez AL, Saas P, Pannetier C, De Tribolet N, Tiercy JM, Aubry JP, Dietrich PY, Walker PR (1999) Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol 11: 1337-1350.
24. Ruffell B, DeNardo DG, Affara NI, Coussens LM (2010) Lymphocytes in cancer development: Polarization towards pro-tumor immunity. Cytokine Growth Factor Rev 21: 3-10.
25. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbl uth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102: 18538-18543.
26. Smyth MJ, Dunn GP, Schreiber RD (2006) Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 90: 1-50.
27. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for gl ioblastoma. N Engl J Med 352: 987-996.
28. Von HRI, Hofman FM, Taylor CR, Apuzzo ML (1984) Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subse ts with monoclonal antibodies. J Neurosurg 60: 1138-1147.
29. Waziri A, Killory B, Ogden 3rd AT, Canoll P, Anderson RC, Kent SC, Anderson DE, Bruce JN (2008) Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma. J Immunol 180: 7673-7680.
30. Yu JS, Lee PK, Ehtesham M, Samoto K, Black KL, Wheeler CJ (2003) Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium. J Neurooncol 64: 55-61.
31. Yue Q, Zhang X, Ye HX, Wang Y, Du ZG, Yao Y, Mao Y (2013) The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. J Neurooncol 116(2): 251-259.
32. Zamarron BF, Chen W (2011) Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 7: 651-658.